Shasun Pharmaceuticals has reported results for first quarter ended June 30, 2012.

The company has reported a surge of 102.34% in its net profit at Rs 13.82 crore for the quarter under review as compared to Rs 6.83 crore for the same quarter in the previous year. The total income from operation of the company has increased by 32.26% at Rs 265.60 crore for Q1FY13 as compared Rs 200.82 crore for the corresponding quarter previous year.

Shasun Pharmaceuticals manufactures active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients with a significant presence in some key generics. Shasun has created a strong product portfolio, building on its R&D Expertise, regulatory capabilities and multi scale production capacities. It is one of the largest producers of Ibuprofen worldwide.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×